Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Obstetrics & Gynaecology

Clinical Pharmacology

Does the effect of adjunctive azithromycin on cesarean infection vary with cefazolin dose?

American Journal of Obstetrics and Gynecology | Jan 18, 2018 Clinical Pharmacology

Pharmacokinetics, antiviral activity, and safety of rilpivirine in pregnant women with HIV-1 infection: Results of a phase 3b, multicenter, open-label study

Infectious Diseases and Therapy | Jan 18, 2018 Clinical Pharmacology

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/HER2-negative breast cancer—The evaluating treatment with neoadjuvant Abraxane (ETNA) trial: A randomized phase 3 clinical trial

JAMA Oncology | Jan 17, 2018 Clinical Pharmacology

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer

Cancer Chemotherapy and Pharmacology | Jan 14, 2018 Clinical Pharmacology

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Gynecologic Oncology | Jan 13, 2018 Clinical Pharmacology

Does antenatal steroids treatment prior to elective cesarean section at 34–37 weeks of gestation reduce neonatal morbidity? Evidence from a case control study

Archives of Gynecology and Obstetrics | Evidence based | Jan 13, 2018 Clinical Pharmacology

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

The Lancet Oncology | Jan 12, 2018 Clinical Pharmacology

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

The Oncologist | Evidence based | Jan 12, 2018 Clinical Pharmacology

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

The Oncologist | Jan 12, 2018 Clinical Pharmacology

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?

European Journal of Obstetrics & Gynecology and Reproductive Biology | Jan 12, 2018 Clinical Pharmacology

« Prev 1 … 95 96 97 98 99 … 106 Next »

Does the effect of adjunctive azithromycin on cesarean infection vary with cefazolin dose?

Pharmacokinetics, antiviral activity, and safety of rilpivirine in pregnant women with HIV-1 infection: Results of a phase 3b, multicenter, open-label study

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/HER2-negative breast cancer—The evaluating treatment with neoadjuvant Abraxane (ETNA) trial: A randomized phase 3 clinical trial

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Does antenatal steroids treatment prior to elective cesarean section at 34–37 weeks of gestation reduce neonatal morbidity? Evidence from a case control study

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Does the effect of adjunctive azithromycin on cesarean infection vary with cefazolin dose?

Pharmacokinetics, antiviral activity, and safety of rilpivirine in pregnant women with HIV-1 infection: Results of a phase 3b, multicenter, open-label study

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/HER2-negative breast cancer—The evaluating treatment with neoadjuvant Abraxane (ETNA) trial: A randomized phase 3 clinical trial

The effect of food on the pharmacokinetics of niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent ovarian cancer

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer

Does antenatal steroids treatment prior to elective cesarean section at 34–37 weeks of gestation reduce neonatal morbidity? Evidence from a case control study

Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study

Bendamustine plus rituximab vs R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: Evidence from a multicenter, retrospective study

Safety profile of biosimilar filgrastim (Zarzio/Zarxio): A combined analysis of phase III studies

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?

Optimising Caesarean Section Practices

New Treatment in Uveitis

Environmental Pollution and Lifestyle Disorders: An Emerging Global Challenge

Anaemia: Types and Management

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Select Specialty

Select Topic